I'm going to save you from yourself right now.
Because the SpaceX IPO is just days away and I already know what you're probably thinking.
You're thinking you'll buy shares the second it goes public, ride the Elon hype, and cash in.
I've seen this movie a hundred times and it ends badly.
Not for Elon, he'll pocket around $625 billion overnight. He'll be fine.
Not for the Wall Street banks who underwrote the deal. They got their slice months ago. They'll be fine too.
The ones who get hurt? Regular people. Those who show up on IPO day, buy at the top, and spend the next six months wondering what went wrong.
I'm not going to sugarcoat this — if your plan is to buy SpaceX like everyone else on opening day, you are the exit liquidity.
That's the game. That's how it's always been.
But here's what pisses me off: it doesn't have to be that way. Not this time.
There's a pre-IPO SpaceX play available right now that almost nobody is talking about. A way to get positioned before the herd stampedes in on day one.
I'm not talking about some waitlist only insiders and millionaires can get on. I'm talking about something you can do today, from a regular brokerage account.
But I'll be blunt — this won't last. Once SpaceX begins trading on public markets, this window slams shut.
So, stop planning your IPO-day buy order and go here instead.
You'll thank me later.
Tim Bohen
5 Spin-Off Stocks That Could Reward Patient Investors in 2026
By Thomas Hughes. Article Posted: 3/26/2026.
Key Points
- Spin-offs are a powerful tool that helps CEOs unleash growth and unlock value for investors.
- Five planned 2026 spin-offs fit the bill and attract bullish analyst ratings.
- The question investors must ask themselves is whether to buy the original, the spinco, or both.
- Special Report: The Biggest IPO Ever: Claim Your Stake Today
Spin-offs are an effective tool for companies to streamline operations, focus on growth, and unlock shareholder value. The key question for investors is whether a separation changes how the original company, the new company, or both should be evaluated as standalone stories.
FedEx on Track to Deliver Value-Building Savings
FedEx’s (NYSE: FDX) spin suggests both the original company and the spin-off could be attractive buys. The separation isolates the freight business from the core package delivery business, enabling both companies to trade at cleaner valuations. A critical takeaway for potential investors in the freight company is that it could trade at a 50% or higher premium relative to the original company. That said, the freight business faces 2026 headwinds, including tepid demand, margin pressure, and expansion costs.
America’s new AI “Manhattan Project” (Ad)
Louis Navellier: Don't buy OR sell another AI stock…
Until you've heard this urgent AI warning from the man who called Nvidia before its 44,000% rise… According to Louis, a massive reset is coming in an obscure corner of the AI market. This $100 trillion disruption could send some of the world's biggest AI stocks to zero… and one off-the-radar stock soaring… starting now.
Click here for details and Louis' new pick — free.
For holders of the remaining FDX, expected benefits include improvements in operational quality, cash flow, and the reliability of capital returns. FedEx’s capital-return program is meaningful, combining dividends, dividend growth, and aggressive share buybacks—buybacks have reduced the share count by more than 2.5% year-to-date as of the end of fiscal Q3 2026. Analysts have been raising price targets ahead of the split, supporting a Moderate Buy rating with potential to reach new highs by mid-year.
KBR Split Enhances Focus, Unlocks Growth Avenues
KBR’s (NYSE: KBR) split and spin-off, slated for the back half of 2026, aims to separate its Sustainable Technology Solutions business from its government-focused operations. The new company will be built around the Mission Technology Solutions group, which includes defense, security, and space applications. One rationale for the move is value unlocking: the spinco could see substantial re-rating—potentially 100% to 200%—based on the original’s roughly 9x multiple. Defense peers such as Lockheed Martin (NYSE: LMT), Northrop Grumman (NYSE: NOC), and RTX (NYSE: RTX) trade at well over 20 times earnings.
While the spinco will focus on defense contracts and execution of its sizable backlog, the remaining company will concentrate on higher-margin sustainable energy technologies. The leaner organizations should benefit from faster decision-making and greater financial flexibility, allowing continued investment in growth. Analyst revisions are mixed for 2026, but the consensus rating remains Hold, with the consensus price target implying roughly a 50% upside.
Medtronic to Spin Off High-Growth Diabetes Unit
Medtronic (NYSE: MDT) plans to spin off its high-growth diabetes unit later this year—an action that may seem counterintuitive at first. The diabetes business is largely consumer-oriented, while Medtronic’s core operations are hospital-focused, creating a strategic mismatch for a combined company. The spin will create a pure-play diabetes equipment and supplies company that can compete more effectively in its fast-growing market and may become an attractive takeover candidate.
The remaining Medtronic will focus on higher-margin, high-growth areas such as cardiovascular and robotic surgery. Robotic surgery is an expanding segment—leaders like Intuitive Surgical (NASDAQ: ISRG) continue to deliver double-digit growth and steady operational improvement. Twenty-six analysts rate this stock a Moderate Buy; coverage is increasing, sentiment is steady, and the consensus price target as of late March implies more than 25% upside.
Keurig Dr Pepper: Grows to Split, Unleashes Global Powerhouses
Keurig Dr Pepper (NASDAQ: KDP) has struggled for years because strengths in one beverage segment have often been offset by weaknesses in another. The company plans another coffee acquisition and then intends to spin off the combined coffee business into a pure-play. That move should create supply-chain efficiencies and unlock growth—particularly in the high-margin coffee pod category.
The ongoing business will become a soda-and-beverage pure-play, unencumbered by coffee-specific issues and with an improved financial profile. It should be better positioned to focus on higher-margin segments and pursue acquisitions; the transaction is expected to complete in April. Analysts are generally bullish, rating KDP a Moderate Buy and raising price targets ahead of the spin-off. MarketBeat’s consensus price target points to roughly 35% upside, with high-end targets adding additional gains.
Honeywell Splits to Enhance Focus With 2 Pure-Play Businesses
Honeywell (NASDAQ: HON) plans to separate its aerospace business into a focused pure-play that will service defense and commercial customers, execute on a record backlog, and strengthen cash flow, while the remaining company concentrates on industrial automation. Industrial automation sits at the heart of Industrial Revolution 4.0 and the convergence of the Internet of Things (IoT), robotics, and AI. The split should provide a more flexible financial position for both companies, enabling strategic acquisitions to sustain long-term growth.
Analyst trends are broadly positive. MarketBeat’s data show expanding coverage, firming sentiment categorized as Moderate Buy, and rising price targets. The consensus forecast called for about 10% upside in late March, with upside skewed toward the higher end and likely to remain strong through year-end.
KB Home's Earnings Slump Puts Dividends and Buybacks at Risk
By Thomas Hughes. Article Posted: 3/27/2026.
Key Points
- KB Home is a high-quality stock whose time will come—later this year or in early 2027 when it returns to growth.
- Capital returns are central to the stock price outlook, but they are contracting along with the business.
- Institutions, analysts, and short-sellers present hurdles and headwinds for investors.
- Special Report: The Biggest IPO Ever: Claim Your Stake Today
KB Home (NYSE: KBH) is a high-quality company that has historically returned significant capital to shareholders. However, several factors suggest Q2 2026 isn’t the best time to buy this construction stock; it may be wiser to wait and watch. Analysts expect continued revenue and earnings contraction, though that trend could end by year‑end.
KB Home may be near its price bottom as March comes to an end; however, there is a meaningful chance of Q2 weakness and further downside in the share price.
America’s new AI “Manhattan Project” (Ad)
Louis Navellier: Don't buy OR sell another AI stock…
Until you've heard this urgent AI warning from the man who called Nvidia before its 44,000% rise… According to Louis, a massive reset is coming in an obscure corner of the AI market. This $100 trillion disruption could send some of the world's biggest AI stocks to zero… and one off-the-radar stock soaring… starting now.
Click here for details and Louis' new pick — free.The critical support level sits near the 2025 lows at $48.90. This level has held since Q2 2025 but is at risk of breaking. Momentum indicators such as the stochastic and the MACD point to weakening conditions and vulnerability to further decline, while the cluster of exponential moving averages is nearing a Death Cross.
The Death Cross is the opposite of a Golden Crossover: it occurs when short-term EMAs cross below a longer-term EMA, signaling a bearish shift in market dynamics. A Death Cross often precedes major sell-offs and could push the stock toward the low end of its long-term range near $25.
Weak Results Signal Risk for KBH Capital Returns
KB Home struggled in fiscal Q1 2026, reporting revenue of $1.07 billion, down roughly 23% year over year (YOY). The miss was notable—the underperformance versus expectations exceeded 180 basis points. The decline was driven by a 14% fall in deliveries and weaker pricing, and forward-looking metrics suggest the weakness will persist. The company’s backlog is down by double digits in both value and home count.
Margins were also under pressure across the board as costs rose and revenue deleveraged. GAAP EPS was $0.52, two cents below MarketBeat’s reported consensus, a decline of roughly 65% YOY, and guidance was weakened further.
Guidance matched the weak quarter: the company is forecasting nearly a 24% contraction, accelerating the sequential decline and falling short of the consensus estimate. The only marginally positive note is that margins are expected to hold steady, but the key takeaway is that margin compression and sales declines have materially reduced earnings power, putting capital returns at risk.
Capital returns are an important support for the stock, including a dividend and buybacks, which reduced the share count by an average of 12.7% YOY. The problem: operating cash flow is currently insufficient to fully cover these payouts, so the company is drawing on its cash pile. That cash should sustain returns for a time, but not indefinitely, and buybacks are already slowing—the Q1 pace was down about 75% YOY, and Q2 forecasts point to a similar pullback. Looking ahead, buybacks may slow to near zero until the company returns to growth and rebuilds capacity to resume repurchases.
Analysts, Institutions, and Short-Sellers Present Headwinds for Investors
Analysts, institutions, and short-sellers—the three groups investors typically want on their side—are not currently bullish on KBH. Analyst coverage remains intact, but the consensus rating has slipped to Hold and price targets are drifting lower.
The existing low target of $25 implies a potential price floor, but it’s not immovable. Additional downgrades or target cuts could push the stock through that level to fresh lows, and there doesn’t appear to be strong buying support at the moment.
Institutions, which own roughly 97% of the stock, have been net sellers on a trailing 12‑month basis and increased activity in Q1, capping gains and contributing to the move to long-term lows. There is little incentive for them to accumulate after the Q1 results and guidance. Meanwhile, short interest—off its highs—remains elevated near 10%, creating an overhang that could grow given the weakened outlook. Given these flows, the KBH market appears to be distributing shares and may continue to do so.
The primary upside catalyst is the company's shift to a built-to-order model, which reduces dependence on speculative or walk-in sales. That strategy is amplifying near-term weakness but could position KB Home to return to growth with stronger margins in 2027.
This email is a paid sponsorship sent on behalf of Timothy Sykes, a third-party advertiser of The Early Bird and MarketBeat.
If you have questions or concerns about your subscription, don't hesitate to contact our South Dakota based support team at contact@marketbeat.com.
If you no longer wish to receive email from The Early Bird, you can unsubscribe.
Copyright 2006-2026 MarketBeat Media, LLC. All rights protected.
345 North Reid Place, Sixth Floor, Sioux Falls, SD 57103. USA..
No comments:
Post a Comment